Optimization of Large-Scale Adeno-Associated Virus (AAV) Production.
Optimization of Large-Scale Adeno-Associated Virus (AAV) Production.
复制标题
大规模腺相关病毒 (AAV) 生产的优化。
DOI:
10.1002/cpz1.757
复制
发表时间:
2023
期刊:
影响因子:
--
通讯作者:
Blackwood,ErikA
中科院分区:
文献类型:
--
作者:
Bilal,AlinaS;Parker,SarahN;Murray,VictoriaB;MacDonnell,LaurenF;Thuerauf,DonnaJ;Glembotski,ChristopherC;Blackwood,ErikA
Genetic manipulationin vivois a critical method for mechanistically understanding gene function in disease and physiological processes. To facilitate this, embryonic transgenesis in popular animal models like mice has been developed. Compared to the longer, expensive methods of transgenesis, viral vectors, such as adeno‐associated virus (AAV), have grown increasingly in popularity due to their relatively low cost and ease of production, translating to an overall greater versatility as a biological tool. In this article, we describe protocols for AAV production and purification for efficient transductionin vivo. Importantly, our method differs from others in application of a streamlined, more cost‐effective approach. From this method, as many as 2 × 1013genome‐containing viral particles (vp), or 200 units, can be produced within 3 to 4 weeks, with a minimal cost of $1800 to $2000 for supplies and reagents and <15 hr of personnel time per week. A unit here is defined as 1 × 1011vp, our standard dose of AAV per animal, injected via tail vein. Therefore, our method provides production and purification of AAV in quantities capable of transducing up to 200 animals. © 2023 The Authors. Current Protocols published by Wiley Periodicals LLC.Basic Protocol 1: AAV productionBasic Protocol 2: AAV purification